Skip to content

From the American College of Rheumatology

Rheumatology for Primary Care
  • Symptoms
    • Fever
    • Joint Pain
    • Muscle Pain and/or Weakness
    • Rashes
    • Raynaud’s Phenomenon
  • Diseases
    • ANCA-Associated Vasculitis
    • Behcet’s Syndrome
    • Crystalline Arthropathies
    • Drug and Medication-Induced Rheumatic Diseases
    • Giant Cell Arteritis
    • Henoch-Schönlein Purpura
    • IgG4-Related Disease
    • Juvenile Dermatomyositis
    • Juvenile Idiopathic Arthritis
    • Kawasaki Disease
    • Mixed Connective Tissue Disease
    • Multisystem Inflammatory Syndrome in Children
    • Myositis
    • Polyarteritis Nodosa
    • Polymyalgia Rheumatica
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjogren’s Disease
    • Spondyloarthritis
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
  • Case Studies
    • ANCA-Associated Vasculitis
    • Behcet’s Syndrome
    • Crystalline Arthropathies
    • Giant Cell Arteritis
    • Henoch-Schönlein Purpura
    • IgG4-Related Disease
    • Juvenile Dermatomyositis
    • Juvenile Inflammatory Arthritis
    • Kawasaki Disease
    • Mixed Connective Tissue Disease
    • Myositis
    • Pediatric Fevers
    • Polyarteritis Nodosa
    • Polymalgia Rheumatica
    • Raynaud’s Phenomenon
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sicca/Sjogren’s Disease
    • Spondyloarthritis
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
  • Labs
  • Meds
    • Commonly Used Rheumatology Meds
    • Treatment Considerations
    • Addressing Patient Fears About Rheumatology Medications
    • Medications by Diseases
  • Resources
    • Resources
    • Vaccination Considerations – Pediatrics
    • Vaccination Considerations – Adults
    • Glossary of Terms
    • ACR Clinical Guidelines
    • ACR Education Center
    • Rheumatology Provider Directory

Glossary

Home ยป Glossary
GlossaryPrimary Care2024-05-21T14:05:43+00:00
AJAX progress indicator
Search: (clear)
Categories All categories Abbreviations Labs Medications
  • Antinuclear Antibody (ANA)
  • AAA
  • AAV
  • Abaloparatide
  • Abatacept
  • Adalimumab
  • AI
  • Aldolase
  • Aledronate
  • Allopurinol
  • Anifrolumab-fnia
  • Anti-cardiolipin Antibodies
  • Anti-citrullinated Protein Antibody (Anti-CCP Ab)
  • Anti-dsDNA (double-stranded DNA)
  • Anti-RNP (ribonucleicprotein)
  • Anti-Smith
  • Anti-SSA (ro antibody)
  • Anti-SSB
  • Apremilast
  • Azathioprine
  • Baricitinib
  • BCP
  • bDMARD
  • Belimumab
  • Beta2Glycoprotein
  • Bisphosphonate Therapy
  • C-ANCA (cytoplasmic anti-neutrophil cytoplasmic antibodies)
  • CADM
  • Canakinumab
  • cDMARD
  • Centromere
  • Certolizumab
  • Colchicine
  • Corticosteroids
  • CPK
  • CPPD
  • CRP
  • Cryoglobulins
  • Cyclophosphamide
  • Cyclosporine
  • Denosumab
  • DIC
  • DM
  • DMARD
  • eGPA
  • EN
  • ESR
  • Etanercept
  • Febuxostat
  • Ferritin
  • GN
  • Golimumab
  • GPA
  • Guselkumab
  • Histone
  • HLA-B27
  • HLA-B51
  • HMG CoA Reductase
  • HSP
  • HUS
  • Hyaluronic Acid
  • Hydroxychloroquine
  • Ibandronate
  • IBM
  • IBMP
  • ICI
  • IgG4-RD
  • IIM
  • IL
  • IL-6
  • ILD
  • IMNM
  • Infliximab
  • Intravenous Methylprednisolone
  • ITP
  • IVIG
  • Ixekizumab
  • JAK
  • JDM
  • Jo-1
  • KU, U1RNP, U2RNP, U3RNP
  • LCV
  • Leflunomide
  • Lesinurad
  • Lupus Anticoagulant
  • MCP
  • MDA5
  • Methotrexate
  • Mi-2
  • Minocycline
  • MPA
  • MSU
  • Mycophenolate
  • Myeloperoxidase (MPO) Antibody
  • Myositis Associated Antibodies
  • MAA
  • Myositis Specific Antibodies
  • MSA
  • Nintedanib
  • NSAIDs
  • NXP-2
  • P-ANCA (Peri-nuclear Anti-neutrophil Cytoplasmic Antibodies)
  • Pegloticase
  • PFAPA
  • PIP
  • PJP
  • PL7, PL12, EJ, OJ
  • PM
  • PM-SCL
  • Prednisone
  • Proteinase 3 (PR-3) Antibody
  • PSGN
  • PTI
  • Rheumatoid Factor (RF)
  • Rilonacept
  • Risankizumab-rzaa
  • Risedronate
  • Rituximab
  • RNA Polymerase III Antibody (rna pol 3)
  • Romosozumab
  • SAPHO
  • Sarilumab
  • Scl-70 (or Anti-topoisomerase I)
  • SCLE
  • Secukinumab
  • SJIA
  • SJS
  • SLE
  • SRP
  • Sulfasalazine
  • TAA
  • Teriparatide
  • TIF-1 (p155/140)
  • TNF
  • Tocilizumab
  • Tofacitinib
  • tsDMARD
  • Tumor Necrosis Factor Inhibitors
  • Upadacitinib
  • Ustekinumab
  • Voclosporin
  • Zoledronic Acid

We Want Your Input

Find what you needed? We would love your feedback so that we can ensure the site meets the needs of primary care providers.

Give Feedback

American College of Rheumatology Information

About ACR

ACR Contacts

Authors

This product was funded by a medical grant from Pfizer. The content was written by a physician work group. See Authors

© Copyright American College of Rheumatology 2025 | All rights reserved | See ACR Policies

Page load link
Go to Top